Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Gentle Alternative For Glaucoma Therapy Announced By Surgeons of North Shore Eye Care
  • USA - English


News provided by

North Shore Eye Care

Feb 25, 2014, 09:00 ET

Share this article

Share toX

Share this article

Share toX


“Our SLT procedure lowers intraocular pressure by an average of 25% in 75-85% of patients treated,” Dr. Bainnson added.

Post this

Smithtown, New York (PRWEB) February 25, 2014 -- Using gentle pulses of light delivered through a specially designed microscope, glaucoma specialists at North Shore Eye Care are able to significantly drop the intraocular pressure within patients eyes that causes glaucoma, according to Andrew Bainnson, M.D., a glaucoma specialist at North Shore Eye Care.
“Our Selective Laser Trabeculoplasty (SLT) laser technique is a non-thermal, non-invasive procedure that that can be repeated if necessary to lower intraocular pressure within the eye,” said Dr. Bainnson, adding that previous approaches in laser therapy were either extremely limited or not repeatable.

According to Dr. Bainnson, patients who could benefit most from SLT treatment include: 1) Patients with primary open-angle, pseudoexfoliation, or pigmentary glaucoma; 2) Patients who are not tolerant to traditional glaucoma medications or treatment; 3) Patients who are currently undergoing glaucoma drug therapy and wish to combine it with SLT; Patients who find it difficult to commit to regular follow-up treatments due to finances, lack of transportation or other limitations; 4) And patients who have a history of failed Argon Laser Trabeculoplasty (ALT) treatments.

“Our SLT treatments have been very successful with the vast majority of our glaucoma patients,” said Glaucoma Specialist, Andrew Bainnson, MD. “Unfortunately, many patients who have glaucoma – and who could benefit from SLT – do not seek treatment because they are unaware they even have glaucoma.” Commonly called ‘The Sneak Thief of Sight,’ glaucoma continues to be one of the world’s leading causes of preventable blindness because there are very few warning signs. “Once vision loss from glaucoma has occurred, it is virtually impossible to restore at this time,” said Dr. Bainnson.

“Our SLT procedure lowers intraocular pressure by an average of 25% in 75-85% of patients treated,” Dr. Bainnson added. North Shore Eye Care offers other forms of treatment – including traditional drug therapy – which can still be highly effective in specific cases.

Glaucoma occurs when the eyes normal drainage system for aqueous fluid is blocked. This build-up of this blocked fluid – which is produced by the body to ensure the health of the lens and cornea – causes intraocular pressure within the eye to increase. This causes what is known as ‘open-angle’ glaucoma, which is the most common form of this vision-threatening disease.

To order to preserve eyesight, it is critically important for our surgeons to not only decrease the intraocular pressure, but to also control and maintain the eyes’ normal pressure. In addition to SLT, other treatment options include: 1) Drug therapy (drops), which is the most common treatment for open-angle glaucoma; 2) Surgery methods to create a new drainage channel, which is a highly invasive procedure; 3) Argon Laser Trabeculoplasty, which was formerly one of the most widely used laser treatments for glaucoma, but carried many risks and possible complications.

Because glaucoma continues to be one of our country’s leading causes of blindness, it is important for adults to have their vision checked for glaucoma on a regular basis. This is especially true in families with a history of glaucoma, patients of African-American descent and patients who may be experiencing vision loss or changes in their vision.

North Shore Eye Care is Long Island’s most established full-service comprehensive eye care provider. This year they are celebrating 50 years of eye care excellence since Dr. Sidney Martin founded the practice in 1962. North Shore Eye Care is also the official Eye Care Provider for the New York Islanders and the official LASIK Providers of the New York Mets. Many of their doctors have been voted ‘TOP DOCTORS’ in the New York Metro Area by Castle Connolly and North Shore Eye Care has earned ‘Best Of Long Island’ honors for the past few years.

North Shore Eye Care maintains offices in Smithtown, Riverhead, Holbrook, Deer Park, Southampton and Southold. They specialize in cataract care, LASIK laser vision correction, glaucoma management, diabetic eye disease, oculoplastics and retinal care.For more information about North Shore Eye Care.

Jacqueline Hernandez, North Shore Eye Care, http://www.nseye.com, 631-265-8780, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.